Breast cancer statistics, 2019
- PMID: 31577379
- DOI: 10.3322/caac.21583
Breast cancer statistics, 2019
Abstract
This article is the American Cancer Society's biennial update on female breast cancer statistics in the United States, including data on incidence, mortality, survival, and screening. Over the most recent 5-year period (2012-2016), the breast cancer incidence rate increased slightly by 0.3% per year, largely because of rising rates of local stage and hormone receptor-positive disease. In contrast, the breast cancer death rate continues to decline, dropping 40% from 1989 to 2017 and translating to 375,900 breast cancer deaths averted. Notably, the pace of the decline has slowed from an annual decrease of 1.9% during 1998 through 2011 to 1.3% during 2011 through 2017, largely driven by the trend in white women. Consequently, the black-white disparity in breast cancer mortality has remained stable since 2011 after widening over the past 3 decades. Nevertheless, the death rate remains 40% higher in blacks (28.4 vs 20.3 deaths per 100,000) despite a lower incidence rate (126.7 vs 130.8); this disparity is magnified among black women aged <50 years, who have a death rate double that of whites. In the most recent 5-year period (2013-2017), the death rate declined in Hispanics (2.1% per year), blacks (1.5%), whites (1.0%), and Asians/Pacific Islanders (0.8%) but was stable in American Indians/Alaska Natives. However, by state, breast cancer mortality rates are no longer declining in Nebraska overall; in Colorado and Wisconsin in black women; and in Nebraska, Texas, and Virginia in white women. Breast cancer was the leading cause of cancer death in women (surpassing lung cancer) in four Southern and two Midwestern states among blacks and in Utah among whites during 2016-2017. Declines in breast cancer mortality could be accelerated by expanding access to high-quality prevention, early detection, and treatment services to all women.
Keywords: breast neoplasms; epidemiology; health disparities; incidence; molecular subtype; mortality.
© 2019 American Cancer Society.
Similar articles
-
Breast cancer statistics 2024.CA Cancer J Clin. 2024 Nov-Dec;74(6):477-495. doi: 10.3322/caac.21863. Epub 2024 Oct 1. CA Cancer J Clin. 2024. PMID: 39352042
-
Breast cancer statistics, 2015: Convergence of incidence rates between black and white women.CA Cancer J Clin. 2016 Jan-Feb;66(1):31-42. doi: 10.3322/caac.21320. Epub 2015 Oct 29. CA Cancer J Clin. 2016. PMID: 26513636
-
Breast Cancer Statistics, 2022.CA Cancer J Clin. 2022 Nov;72(6):524-541. doi: 10.3322/caac.21754. Epub 2022 Oct 3. CA Cancer J Clin. 2022. PMID: 36190501
-
Breast cancer statistics, 2013.CA Cancer J Clin. 2014 Jan-Feb;64(1):52-62. doi: 10.3322/caac.21203. Epub 2013 Oct 1. CA Cancer J Clin. 2014. PMID: 24114568 Review.
-
Breast cancer statistics, 2011.CA Cancer J Clin. 2011 Nov-Dec;61(6):409-18. doi: 10.3322/caac.20134. Epub 2011 Oct 3. CA Cancer J Clin. 2011. PMID: 21969133 Review.
Cited by
-
A Population-Based Analysis of the Cancer Incidence in Individuals under 50 in a Northern Italian Province: Focusing on Regional Disparities and Public Health Implications.Int J Environ Res Public Health. 2024 Oct 8;21(10):1333. doi: 10.3390/ijerph21101333. Int J Environ Res Public Health. 2024. PMID: 39457306 Free PMC article.
-
Deep Learning Image Analysis of Benign Breast Disease to Identify Subsequent Risk of Breast Cancer.JNCI Cancer Spectr. 2021 Jan 11;5(1):pkaa119. doi: 10.1093/jncics/pkaa119. eCollection 2021 Feb. JNCI Cancer Spectr. 2021. PMID: 33644680 Free PMC article.
-
Synthesis, Characterisation and Mechanism of Action of Anticancer 3-Fluoroazetidin-2-ones.Pharmaceuticals (Basel). 2022 Aug 24;15(9):1044. doi: 10.3390/ph15091044. Pharmaceuticals (Basel). 2022. PMID: 36145265 Free PMC article.
-
Deciphering the Immune Microenvironment at the Forefront of Tumor Aggressiveness by Constructing a Regulatory Network with Single-Cell and Spatial Transcriptomic Data.Genes (Basel). 2024 Jan 15;15(1):100. doi: 10.3390/genes15010100. Genes (Basel). 2024. PMID: 38254989 Free PMC article.
-
Young Women with Breast Cancer: The Current Role of Precision Oncology.J Pers Med. 2023 Nov 20;13(11):1620. doi: 10.3390/jpm13111620. J Pers Med. 2023. PMID: 38003935 Free PMC article. Review.
References
-
- Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence-SEER 9 Regs Research Data with Delay-Adjustment, Malignant Only, based on the November 2018 submission. National Cancer Institute, Surveillance Research Program, Surveillance Systems Branch; 2019.
-
- Surveillance, Epidemiology, and End Results (SEER) Program. Breast Schema for 1988-2015 Based on AJCC 6th Edition. Accessed August 8, 2019. seer.cancer.gov/seerstat/variables/seer/ajcc-stage/6th/breast.html
-
- Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence-SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2018 Submission (2000-2016) <Katrina/Rita Population Adjustment>-Linked To County Attributes-Total U.S., 1969-2017 Counties. National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program; 2019.
-
- Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: North American Association of Central Cancer Registries (NAACCR) Incidence Data-Cancer in North America (CiNA) Analytic File, 1995-2015, for NHIAv2 Origin, Custom File With County, American Cancer Society (ACS) Facts and Figures Projection Project (which includes data from the Centers for Disease and Prevention's [CDC's] National Program of Cancer Registries [NPCR], the Canadian Council of Cancer Registry's [CCCR's] Provincial and Territorial Registries, and the National Cancer Institute's [NCI's] SEER Registries). NAACCR; 2018.
-
- Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: North American Association of Central Cancer Registries (NAACCR) Incidence Data-Cancer in North America (CiNA) Analytic File, 1995-2016, for Expanded Races, Custom File With County, American Cancer Society (ACS) Facts and Figures Projection Project (which includes data from the Centers for Disease and Prevention's [CDC's] National Program of Cancer Registries [NPCR], the Canadian Council of Cancer Registry's [CCCR's] Provincial and Territorial Registries, and the National Cancer Institute's [NCI's] SEER Registries). NAACCR; 2018.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous